{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06502353",
            "orgStudyIdInfo": {
                "id": "75139"
            },
            "secondaryIdInfos": [
                {
                    "id": "Pro00074534",
                    "type": "OTHER",
                    "domain": "Advarra"
                }
            ],
            "organization": {
                "fullName": "Plexaa Ltd",
                "class": "INDUSTRY"
            },
            "briefTitle": "Plexaa For Preconditioning: Gender Affirming Mastectomy",
            "officialTitle": "A Pilot Study to Investigate the Use of the Plexaa Preconditioning Device (BLOOM43) for Gender Affirming Mastectomy - a Prospective Cohort Study",
            "acronym": "P4PGAM",
            "therapeuticArea": [
                "Other"
            ],
            "study": "plexaa-for-preconditioning-gender-affirming-mastectomy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-08-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-06-26",
            "studyFirstSubmitQcDate": "2024-07-08",
            "studyFirstPostDateStruct": {
                "date": "2024-07-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Plexaa Ltd",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Stanford University",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to evaluate the use of the Plexaa preconditioning device (BLOOM43) in transgender and non-binary patients undergoing gender affirming mastectomy. This study aims to understand a participant's experience of the device, including its usability and acceptability.\n\nParticipants will use the device to precondition their right breast the evening before undergoing surgery (gender affirming mastectomy)."
        },
        "conditionsModule": {
            "conditions": [
                "Nipple Necrosis",
                "Nipple Graft Loss"
            ],
            "keywords": [
                "Nipple necrosis",
                "Nipple graft loss",
                "Preconditioning"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "All participants (single arm)",
                    "type": "EXPERIMENTAL",
                    "description": "Each patient will be given the device, BLOOM43, for use at home. It will be worn in a patient's existing bra over their right breast and the preconditioning protocol will be done 12 hours before surgery - i.e. the evening before. Patients will then attend their breast surgery the next day as planned.",
                    "interventionNames": [
                        "Device: BLOOM43"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "BLOOM43",
                    "description": "Heat preconditioning",
                    "armGroupLabels": [
                        "All participants (single arm)"
                    ],
                    "otherNames": [
                        "Plexaa preconditioning device"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Participant experience",
                    "description": "Participants' experience of the device will be evaluated with the use of a questionnaire. Most of the questions will consist of multiple-choice components with a five-point scale and there will also be a section for further comments from participants.",
                    "timeFrame": "30 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Compliance",
                    "description": "Proportion of participants who are compliant with the preconditioning protocol",
                    "timeFrame": "1 day"
                },
                {
                    "measure": "Nipple necrosis/nipple graft loss",
                    "description": "Proportion of participants experiencing partial or complete nipple necrosis/nipple graft loss and the rate of hospital readmission due to this",
                    "timeFrame": "30 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* All transgender or non-binary patients over the age of 18 years (no maximum age limit)\n* Patients undergoing peri-areolar mastectomy or double incision mastectomy with a free nipple graft for gender affirmation\n\nExclusion Criteria:\n\n* Patients undergoing surgery for breast cancer\n* Delayed (two-stage) breast reconstruction patients\n* Patients undergoing simple mastectomy or wide local excision of a breast tumour\n* Presence of open breast skin wounds, or infected or inflamed breast skin\n* Presence of a cardiac pacemaker, defibrillator or any other implantable electronic device",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Saahil Mehta",
                    "role": "CONTACT",
                    "phone": "447711183551",
                    "email": "saahil@plexaa.com"
                },
                {
                    "name": "Hadyn Kankam",
                    "role": "CONTACT",
                    "phone": "447539351830",
                    "email": "hadyn@plexaa.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Dung Nguyen",
                    "affiliation": "Stanford University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Division of Plastic & Reconstructive Surgery, Stanford University",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dung Nguyen",
                            "role": "CONTACT",
                            "phone": "650-498-6004",
                            "email": "nguyendh@stanford.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "28075632",
                    "type": "BACKGROUND",
                    "citation": "Meerwijk EL, Sevelius JM. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. Am J Public Health. 2017 Feb;107(2):e1-e8. doi: 10.2105/AJPH.2016.303578."
                },
                {
                    "pmid": "35646495",
                    "type": "BACKGROUND",
                    "citation": "Rifkin WJ, Robinson IS, Kloer C, Cripps CN, Boyd CJ, Blasdel G, Zhao LC, Bluebond-Langner R. Gender-affirming Mastectomy: Comparison of Periareolar and Double Incision Patterns. Plast Reconstr Surg Glob Open. 2022 May 25;10(5):e4356. doi: 10.1097/GOX.0000000000004356. eCollection 2022 May."
                },
                {
                    "pmid": "34307093",
                    "type": "BACKGROUND",
                    "citation": "Perez-Alvarez IM, Zolper EG, Schwitzer J, Fan KL, Del Corral GA. Incidence of Complications in Chest Wall Masculinization for the Obese Female-to-Male Transgender Population: A Case Series. World J Plast Surg. 2021 May;10(2):14-24. doi: 10.29252/wjps.10.2.14."
                },
                {
                    "pmid": "32505626",
                    "type": "BACKGROUND",
                    "citation": "Kankam HKN, Mehta S, Jain A. Thermal Preconditioning for Surgery: A Systematic Review. J Plast Reconstr Aesthet Surg. 2020 Sep;73(9):1645-1664. doi: 10.1016/j.bjps.2020.05.025. Epub 2020 May 21."
                },
                {
                    "pmid": "24011908",
                    "type": "BACKGROUND",
                    "citation": "Mehta S, Rolph R, Cornelius V, Harder Y, Farhadi J. Local heat preconditioning in skin sparing mastectomy: a pilot study. J Plast Reconstr Aesthet Surg. 2013 Dec;66(12):1676-82. doi: 10.1016/j.bjps.2013.07.034. Epub 2013 Sep 4."
                },
                {
                    "pmid": "30656059",
                    "type": "BACKGROUND",
                    "citation": "Mehta S, Cro SC, Coomber B, Rolph R, Cornelius V, Farhadi J. A randomised controlled feasibility trial to evaluate local heat preconditioning on wound healing after reconstructive breast surgery: the preHEAT trial. Pilot Feasibility Stud. 2019 Jan 11;5:5. doi: 10.1186/s40814-019-0392-y. eCollection 2019."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009336",
                    "term": "Necrosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12284",
                    "name": "Necrosis",
                    "asFound": "Necrosis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}